@article{977bda44a916402f91ca1471a173e610,
title = "Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants",
abstract = "The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitric oxide (iNO) compared with placebo in infants with respiratory failure. This follow-up study evaluated respiratory, neurodevelopmental, and other outcomes for infants entered into the European Union Nitric Oxide trial to age 2 years.",
keywords = "Administration, Inhalation, Bronchodilator Agents, Child, Preschool, European Union, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Nitric Oxide, Respiratory Distress Syndrome, Newborn, Survival Rate, developmental outcomes, growth, inhaled nitric oxide, premature infants, randomized controlled trial, Administration, Inhalation, Bronchodilator Agents, Child, Preschool, European Union, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Nitric Oxide, Respiratory Distress Syndrome, Newborn, Survival Rate, developmental outcomes, growth, inhaled nitric oxide, premature infants, randomized controlled trial",
author = "Costantino Romagnoli and Giovanni Vento",
year = "2013",
doi = "10.1542/peds.2013-0007",
language = "English",
volume = "132",
pages = "e695--e703",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics:141 Northwest Point Boulevard:Elk Grove Village, IL 60007:(800)433-9016, (847)434-4000, EMAIL: journals@aap.org, INTERNET: http://www.aap.org, Fax: (847)434-8000",
}